Sivik Global Healthcare is an investment fund managing more than $224 million ran by William Bruce. There are currently 37 companies in Mr. Bruce’s portfolio. The largest investments include Eli Lilly Co and Novo-nordisk A/s, together worth $26.4 million.
As of 22nd July 2024, Sivik Global Healthcare’s top holding is 15,000 shares of Eli Lilly Co currently worth over $13.6 million and making up 6.1% of the portfolio value.
In addition, the fund holds 90,000 shares of Novo-nordisk A/s worth $12.8 million.
The third-largest holding is Mckesson worth $10.5 million and the next is Tenet Healthcare worth $9.31 million, with 70,000 shares owned.
Currently, Sivik Global Healthcare's portfolio is worth at least $224 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Sivik Global Healthcare office and employees reside in Greenwich, Connecticut. According to the last 13-F report filed with the SEC, William Bruce serves as the CCO at Sivik Global Healthcare.
In the most recent 13F filing, Sivik Global Healthcare revealed that it had opened a new position in
Merck Co and bought 65,874 shares worth $8.16 million.
The investment fund also strengthened its position in Mckesson by buying
3,000 additional shares.
This makes their stake in Mckesson total 18,000 shares worth $10.5 million.
Mckesson dropped approximately 0.1% in the past year.
On the other hand, there are companies that Sivik Global Healthcare is getting rid of from its portfolio.
Sivik Global Healthcare closed its position in Spdr Sp Biotech Etf on 29th July 2024.
It sold the previously owned 135,588 shares for $12.1 million.
William Bruce also disclosed a decreased stake in Tenet Healthcare by 0.5%.
This leaves the value of the investment at $9.31 million and 70,000 shares.
The two most similar investment funds to Sivik Global Healthcare are Stonebridge Capital Management Inc and Rockshelter Capital Management. They manage $224 million and $224 million respectively.
Sivik Global Healthcare’s portfolio is diversified across 4 sectors.
Currently, their heaviest sector is Health Care — making up 63.2% of
the total portfolio value.
The fund focuses on investments in the United States as
73.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
49% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $43.2 billion.
These positions were updated on July 29th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Eli Lilly Co |
No change
15,000
|
$13,581,000 | 6.06% |
| Novo-nordisk A/s |
No change
90,000
|
$12,847,000 | 5.74% |
| Spdr Sp Biotech Etf |
Closed
135,588
|
$12,107,000 | |
| Mckesson Corporation |
20.00%
18,000
|
$10,513,000 | 4.69% |
| Tenet Healthcare Corp. |
51.72%
70,000
|
$9,312,000 | 4.16% |
| Boston Scientific Corp. |
28.13%
115,000
|
$8,856,000 | 3.95% |
| Stryker Corp. |
10.71%
25,000
|
$8,506,000 | 3.80% |
| Merck Co |
Opened
65,874
|
$8,155,000 | 3.64% |
| HCA Healthcare Inc |
37.50%
25,000
|
$8,032,000 | 3.59% |
| Intuitive Surg |
22.22%
17,500
|
$7,785,000 | 3.48% |
| Thermo Fisher Scientific Inc. |
16.67%
14,000
|
$7,742,000 | 3.46% |
| Danaher Corp. |
20.00%
30,000
|
$7,496,000 | 3.35% |
| Univ Health Svc |
40.74%
40,000
|
$7,397,000 | 3.30% |
| Vertex Pharmaceuticals, Inc. |
20.00%
15,000
|
$7,031,000 | 3.14% |
| Biogen Inc |
20.00%
30,000
|
$6,955,000 | 3.11% |
| Medtronic Plc |
Closed
80,000
|
$6,590,000 | |
| Zimmer Biomet Holdings Inc |
Closed
50,000
|
$6,085,000 | |
| Surgery Partners Inc |
25.00%
250,000
|
$5,948,000 | 2.66% |
| Cardinal Health, Inc. |
50.00%
60,000
|
$5,899,000 | 2.63% |
| Cencora Inc. |
30.00%
26,000
|
$5,858,000 | 2.62% |
| Becton Dickinson Co |
Opened
25,000
|
$5,843,000 | 2.61% |
| Abbott Laboratories |
Closed
52,500
|
$5,779,000 | |
| Resmed Inc. |
50.00%
30,000
|
$5,743,000 | 2.56% |
| Inspire Medical Systems Inc |
Closed
27,500
|
$5,594,000 | |
| Edwards Lifesciences Corp |
Opened
60,000
|
$5,542,000 | 2.47% |
| Acadia Healthcre |
11.11%
80,003
|
$5,403,000 | 2.41% |
| Biomarin Pharmaceutical Inc. |
Closed
55,000
|
$5,303,000 | |
| Avantor, Inc. |
Opened
250,000
|
$5,300,000 | 2.37% |
| Unitedhealth Group Inc |
Closed
10,000
|
$5,265,000 | |
| Cigna Group/the |
Closed
17,500
|
$5,240,000 | |
| Select Medical Holdings Corporation |
42.00%
145,000
|
$5,084,000 | 2.27% |
| Insulet Corporation |
5.66%
25,000
|
$5,045,000 | 2.25% |
| Encompass Health Corp |
38.89%
55,000
|
$4,718,000 | 2.11% |
| DaVita Inc |
Closed
45,000
|
$4,714,000 | |
| Agilent Technologies Inc. |
Opened
35,000
|
$4,537,000 | 2.03% |
| West Pharmaceutical Services, Inc. |
Opened
13,000
|
$4,282,000 | 1.91% |
| Quest Diagnostics, Inc. |
Closed
30,000
|
$4,136,000 | |
| Smith Nephew |
21.05%
150,000
|
$3,717,000 | 1.66% |
| Laboratory Corp Of America Ho |
Closed
15,000
|
$3,409,000 | |
| Dexcom Inc |
40.00%
30,000
|
$3,401,000 | 1.52% |
| Baxter International Inc. |
Opened
100,000
|
$3,345,000 | 1.49% |
| Teva Pharm Adr |
Opened
200,000
|
$3,250,000 | 1.45% |
| Natera Inc |
Opened
30,000
|
$3,249,000 | 1.45% |
| Maravai Lifesciences Hldgs-a |
119.25%
450,000
|
$3,222,000 | 1.44% |
| Medpace Holdings Inc |
Opened
7,500
|
$3,089,000 | 1.38% |
| Humana Inc. |
50.00%
7,500
|
$2,802,000 | 1.25% |
| Bruker Corp |
Opened
40,000
|
$2,552,000 | 1.14% |
| Qiagen NV |
Closed
55,000
|
$2,389,000 | |
| Walgreens Boots Alliance Inc |
Closed
90,000
|
$2,350,000 | |
| Stevanato Group Spa |
Closed
80,000
|
$2,183,000 | |
| Repligen Corp. |
Opened
15,000
|
$1,891,000 | 0.84% |
| No transactions found | |||
| Showing first 500 out of 51 holdings | |||